Search Results 81-90 of 19714 for Receptor

1. A Study of Using Palbociclib Combined with Standard Adjuvant Endocrine Therapy versus Standard Adjuvant Endocrine Therapy Alone for Hormone Receptor Positive/ Human Epidermal Growth Factor Receptor 2 Negative Early Breast Cancer - Mayo Clinic

   ... Receptor Positive/ Human Epidermal Growth Factor Receptor 2 Negative Early Breast Cancer. Print details. Share; Facebook · Twitter. Overview; Participation ...

2. About CAR-T cell therapy - Mayo Clinic

   To make CAR-T cells, the collected T cells are genetically treated in the lab to produce special receptors called chimeric antigen receptors, or CARs. These ...

3. Fluoroestradiol f 18 (intravenous route) - Side effects & uses - Mayo Clinic

   This medicine is not used to detect other types of lesion receptors, including human epidermal growth factor receptor 2 (HER2) and progesterone receptor (PR).

4. How Do Smoker's Brains Change in Response to High Nicotine Levels? - Mayo Clinic News Network

   This pleasure response to dopamine is a big part of the nicotine addiction process. Over time, as you continue to smoke, the number of nicotine receptors in ...

5. Study of Radium-223 Dichloride Versus Placebo and Treatment With Exemestane / Everolimus in Subjects With Bone Predominant HER2 (Human Epidermal Growth Factor Receptor 2) Negative Hormone Receptor Positive Metastatic Breast Cancer - Mayo Clinic

   ... Receptor 2) Negative Hormone Receptor Positive Metastatic Breast Cancer ... receptor 2 (HER2) negative hormone receptor positive breast cancer with bone ...

6. Losartan (oral route) - Side effects & dosage - Mayo Clinic

   Lowering blood pressure may reduce the risk of strokes and heart attacks. Losartan is an angiotensin II receptor blocker (ARB). It works by blocking a substance ...

7. New and novel treatments for hyperlipidemia - Mayo Clinic

   Clinical outcome trials study the use of human monoclonal antibodies to target biochemical pathways that impact LDL receptor availability and monoclonal ...

8. Publications - Ephraim E. Parent, M.D., Ph.D. - Mayo Clinic

   Zirconium- 89 Labeled Antibody K1-70 for PET Imaging of Thyroid-stimulating Hormone Receptor Expression in Thyroid Cancer. Mol Imaging Biol. 2024 Oct; 26(5): ...

9. A Study of Pembrolizumab (MK-3475) Versus Placebo in Combination with Neoadjuvant Chemotherapy & Adjuvant Endocrine Therapy in the Treatment of Early-Stage Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative (ER+/HER2-) Breast Cancer - Mayo Clinic

   ... Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative (ER+/HER2-) Breast Cancer. Print details. Share; Facebook · Twitter. Overview ...

10. Study of Trastuzumab Deruxtecan (T-DXd) vs Investigator's Choice Chemotherapy in HER2-low, Hormone Receptor Positive, Metastatic Breast Cancer - Mayo Clinic

    ... receptor (HER)2-low, hormone receptor (HR) positive breast cancer patients whose disease has progressed on endocrine therapy in the metastatic setting.